Asher P. Mullard
Bangor, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 677 publications
Un-siloed biomedical opportunities.
Journal: Nature reviews. Drug discovery
Published: September 07, 2026
Newest glue degrader nabs multiple myeloma approval.
Journal: Nature reviews. Drug discovery
Published: September 05, 2026
RevMed's RAS inhibitor gains landmark FDA approval for pancreatic cancer.
Journal: Nature reviews. Drug discovery
Published: August 27, 2026
Lilly spends US$2.8 billion on psychedelic drugs for mental health.
Journal: Nature reviews. Drug discovery
Published: August 07, 2026
First dual BAFF and APRIL inhibitor nabs FDA approval.
Journal: Nature reviews. Drug discovery
Published: August 07, 2026
Oral macrocyclic PCSK9 inhibitor secures FDA approval.
Journal: Nature reviews. Drug discovery
Published: July 30, 2026
CAR T cell therapy for solid cancer scores first approval in China.
Journal: Nature reviews. Drug discovery
Published: July 08, 2026
FDA approves second IGF-1R-targeted antibody for thyroid eye disease.
Journal: Nature reviews. Drug discovery
Published: July 08, 2026
FDA approves novel cell therapy made with haematopoietic stem cells, Tregs and T cells.
Journal: Nature reviews. Drug discovery
Published: July 08, 2026
Can multispecific biologics break the efficacy ceiling?
Journal: Nature reviews. Drug discovery
Published: June 18, 2026
Multispecific T-cell engagers attract cancer drug developers.
Journal: Nature reviews. Drug discovery
Published: June 18, 2026
Last Updated: 09/26/2026